Hinge Health (NYSE:HNGE) President James Pursley Sells 33,000 Shares

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 33,000 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $69.31, for a total value of $2,287,230.00. Following the completion of the transaction, the president directly owned 740,897 shares of the company’s stock, valued at $51,351,571.07. The trade was a 4.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Tuesday, May 26th, James Pursley sold 16,000 shares of Hinge Health stock. The shares were sold at an average price of $53.79, for a total value of $860,640.00.

Hinge Health Stock Up 1.7%

Shares of HNGE stock traded up $1.16 during trading hours on Tuesday, hitting $70.01. 1,297,201 shares of the company’s stock were exchanged, compared to its average volume of 1,378,244. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $71.44. The firm has a market cap of $5.42 billion and a P/E ratio of -5.67. The firm has a 50 day moving average of $54.11 and a two-hundred day moving average of $46.84.

Hinge Health (NYSE:HNGE) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. The firm had revenue of $182.31 million for the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. Hinge Health’s revenue was up 47.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.30 EPS. On average, equities analysts forecast that Hinge Health Inc. will post 1.33 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. KeyCorp lifted their price objective on Hinge Health from $75.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, June 12th. Evercore reissued an “outperform” rating and set a $45.00 target price on shares of Hinge Health in a report on Wednesday, April 8th. Stifel Nicolaus set a $79.00 price target on Hinge Health in a research note on Wednesday, June 10th. Royal Bank Of Canada boosted their price target on Hinge Health from $65.00 to $75.00 and gave the stock an “outperform” rating in a research report on Thursday, June 11th. Finally, Piper Sandler restated an “overweight” rating on shares of Hinge Health in a report on Wednesday, June 10th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Hinge Health currently has an average rating of “Moderate Buy” and a consensus target price of $75.13.

Institutional Trading of Hinge Health

Several institutional investors have recently made changes to their positions in the company. Wells Fargo & Company MN grew its position in Hinge Health by 160.0% in the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after acquiring an additional 336 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in Hinge Health in the fourth quarter valued at $26,000. First Horizon Corp lifted its stake in shares of Hinge Health by 163.9% in the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after purchasing an additional 531 shares during the last quarter. CENTRAL TRUST Co purchased a new position in shares of Hinge Health during the 1st quarter worth $37,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of Hinge Health during the 3rd quarter worth $49,000.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.